HomeProductsBioactive CompoundsEpigeneticsEpigenetic Reader DomainFhd-286
Chemical structure of CAS 2671128-05-3

Fhd-286

In Stock•Starting at $181 for 1 mg•Purity ≥ 97%
CAS No.2671128-05-3
MDL No.MFCD34662947
MFC24H30N6O6S2
MW562.70
InChI KeyJBLQNFBXKOAIHG-FCEWJHQRSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
1 mg98% 99.9+% ee$181In Stock
5 mg98% 99.9+% ee$370In Stock
10 mg98% 99.9+% ee$539In Stock
100 mg>97%$818In Stock
250 mg>97%$1360In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

FHD-286 is a selective oral inhibitor of SMARCA4/SMARCA2 ATPase (BRG1 and BRM), with potential for research into BAF (BRG1/BRM-associated factor)-related disorders, including acute myeloid leukemia.

CAS No.2671128-05-3
Product NameFhd-286

Associated Conditions

neoplasm
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

The influence of organic phosphates on the Bohr effect of human hemoglobin valency hybrids.

Biophysical chemistry • Vol. 4, Issue 3 • 1976
PMID: 7327DOI: 10.1016/0301-4622(76)80068-3

Documentation